Related Experiment Video
Updated: Mar 15, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Technical advances in external radiotherapy for hepatocellular carcinoma
Shin-Hyung Park1, Jae-Chul Kim1, Min Kyu Kang1
1Shin-Hyung Park, Department of Radiation Oncology, Kyungpook National University Hospital, Daegu 41944, South Korea.
Advanced radiotherapy techniques like intensity-modulated radiotherapy and stereotactic ablative body radiotherapy improve hepatocellular carcinoma (HCC) treatment. Future research should identify patients who best benefit from these precise radiation therapies.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Background:
- Hepatocellular carcinoma (HCC) treatment has evolved with advancements in radiotherapy.
- Early adoption of 3-dimensional conformal radiotherapy paved the way for more sophisticated techniques.
Purpose of the Study:
- To review the advancements in radiotherapy for hepatocellular carcinoma (HCC).
- To highlight the efficacy and precision of modern radiotherapy techniques in HCC management.
Main Methods:
- Review of advanced radiotherapy modalities including intensity-modulated radiotherapy (IMRT), stereotactic ablative body radiotherapy (SABR), and charged particle therapy.
- Discussion of the role of advanced imaging in radiotherapy planning and delivery for HCC.
- Analysis of reported local control rates and toxicity profiles associated with these techniques.
Main Results:
- IMRT allows dose escalation while sparing normal tissues, beneficial for large or critically located HCC tumors.
- SABR achieves high local control rates (84%-100%) for small HCCs using hypofractionated high-dose radiation.
- Advanced techniques enable high-dose radiotherapy for various stages of HCC with manageable toxicities.
Conclusions:
- Modern radiotherapy techniques offer precise and effective treatment options for hepatocellular carcinoma.
- The lack of predictive tools for treatment response and recurrence necessitates future research focused on patient selection for radiotherapy.
More Related Videos
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013